Source:http://linkedlifedata.com/resource/pubmed/id/21402241
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-3-15
|
pubmed:abstractText |
Severe sepsis is an infection-induced inflammatory syndrome that can lead to multi-organ dysfunction and continues to be a major cause of morbidity and mortality worldwide. Because numerous cascades are triggered during sepsis, selective blocking of inflammatory mediators may be insufficient to arrest this process, and recent therapeutic approaches have proven controversial. Statins are the most commonly prescribed agents for hypercholesterolaemia and dominate the area of cardiovascular risk reduction. Moreover, these drugs have a variety of actions that are independent of their lipid lowering effect. Such anti-inflammatory, antioxidant, immunomodulatory, and antiapoptotic features have been collectively referred to as pleiotropic effects. By virtue of their pleiotropic effects, statins have also emerged as potentially useful in various critical care areas such as bacteraemia, the early phases of sepsis and septic shock, as well as the management of serious infections. This review outlines current evidence on the use of statins for preventing and treating sepsis.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1879-0828
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
125-33
|
pubmed:dateRevised |
2011-9-2
|
pubmed:meshHeading |
pubmed-meshheading:21402241-Animals,
pubmed-meshheading:21402241-Bacteremia,
pubmed-meshheading:21402241-Humans,
pubmed-meshheading:21402241-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:21402241-Infection,
pubmed-meshheading:21402241-Prospective Studies,
pubmed-meshheading:21402241-Retrospective Studies,
pubmed-meshheading:21402241-Sepsis,
pubmed-meshheading:21402241-Shock, Septic
|
pubmed:year |
2011
|
pubmed:articleTitle |
Statins in prevention and treatment of severe sepsis and septic shock.
|
pubmed:affiliation |
Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
|
pubmed:publicationType |
Journal Article,
Review
|